Figure 6.
Enhanced proliferative expansion of cardiomyocytes in GSNOR−⁄− hearts post MI A and B, BrdU incorporation by cardiomyocytes in WT (A, arrows) and GSNOR−⁄− (B, arrowheads) hearts, 1 month post MI. C, Quantification of BrdU+ cardiomyocytes reveals that, compared with WT,GSNOR−⁄− hearts are characterized by a 3-fold increase in cardiomyocyte proliferation in their infarct zone (IZ) (1-way ANOVA, *P<0.0001). Values are mean±SEM. ANOVA indicates analysis of variance; BrdU, 5-bromodeoxyuridine; BZ, border zone; CMs, cardiomyocytes; GSNOR, S-nitrosoglutathione reductase; MI, myocardial infarction; RZ, remote zone; WT, wild-type.